CASGEVY Makes History as FDA Approves First CRISPR/Cas9 Genome Edited Therapy.
Human gene therapy, 35(1-2): 1-4 PMID 38231658 DOI 10.1089/hum.2023.29263.bfs
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.